Clinical Trial Update: Inhaled Nitrous Oxide for Treatment-Resistant Depression: Optimizing Dosing Strategies [Phase 2]

View source ↗

Summary

Phase 2 trial investigating inhaled nitrous oxide for treatment-resistant depression; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder Major
• Depressive Disorder Treatment-resistant

Drugs mentioned

• Nitrous oxide (inhaled) (nitrous oxide)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant | Phase 2 | Status: COMPLETED | Results posted: 2022-04-04